Business Context and Reporting Period
Colombier Acquisition Corp. III, a Cayman Islands emerging growth company, filed this Form 8-K on February 5, 2026, to report the consummation of its initial public offering (IPO). The company is incorporated in the Cayman Islands with principal executive offices in Palm Beach, Florida.
Key Financial Metrics
- Gross Proceeds: $299,000,000 from the IPO of 29,900,000 Units at $10.00 per Unit (including 3,900,000 Units from the full exercise of the underwriters' over-allotment option).
- Private Placement Proceeds: $1,500,000 from the sale of 150,000 Private Placement Units to the sponsor at $10.00 per unit.
- Total Capital Raised: $300,500,000.
- Trust Account Funding: $299,000,000 ($10.00 per Unit) was deposited into a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company. This amount includes $298,825,000 from net IPO proceeds and $175,000 from private placement proceeds.
- Underwriting Fees: Includes a deferred discount of up to $3,000,000, which may be reduced to $850,000 under certain circumstances.
- Warrant Terms: Each whole warrant is exercisable for one Class A ordinary share at $11.50 per share.
Material Changes
This filing represents the company's initial public offering and transition from a private entity to a public company listed on the New York Stock Exchange. There is no prior comparable period for revenue or operating metrics as the company has not yet commenced operations beyond the IPO.
Outlook, Risks, and Unusual Items
- Securities Registered: Units (CLBR U), Class A ordinary shares (CLBR), and Warrants (CLBR WS) are registered on the NYSE.
- Financial Statements: An audited balance sheet as of February 5, 2026, reflecting the IPO and private placement proceeds, is included as Exhibit 99.1.
- Contingencies: The deferred underwriting discount is subject to reduction based on the terms of the underwriting agreement dated February 3, 2026, with Roth Capital Partners, LLC.
Investor Verification Checklist
- Verify the final amount of the deferred underwriting discount ($3,000,000 vs. potential reduction to $850,000).
- Review the audited balance sheet (Exhibit 99.1) to confirm the exact cash position and liabilities post-IPO.
- Confirm the specific terms regarding the redemption of warrants and the conditions for the reduction of the deferred discount.
- Check for any subsequent filings regarding the identification of a target business for acquisition.